Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 3
1997 5
1998 4
2007 3
2008 1
2010 1
2011 1
2012 1
2013 1
2014 3
2015 3
2016 1
2017 7
2018 4
2019 2
2020 1
2021 2
2022 6
2023 5
2024 9
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma.
Gagelmann N, Dima D, Merz M, Hashmi H, Ahmed N, Tovar N, Oliver-Caldés A, Stölzel F, Rathje K, Fischer L, Born P, Schäfer L, Albici AM, Schub N, Kfir-Erenfeld S, Assayag M, Asherie N, Wulf GG, Kharboutli S, Müller F, Shune L, Davis JA, Anwer F, Vucinic V, Platzbecker U, Ayuk F, Kröger N, Khouri J, Gurnari C, McGuirk J, Stepensky P, Abdallah AO, Fernández de Larrea C. Gagelmann N, et al. Among authors: assayag m. J Clin Oncol. 2024 May 10;42(14):1665-1675. doi: 10.1200/JCO.23.02232. Epub 2024 Feb 15. J Clin Oncol. 2024. PMID: 38358946 Free PMC article.
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma.
Kfir-Erenfeld S, Asherie N, Lebel E, Vainstein V, Assayag M, Dubnikov Sharon T, Grisariu S, Avni B, Elias S, Alexander-Shani R, Bessig N, Shehadeh A, Ishtay A, Zelmanovich V, Zimran E, Pick M, Roziner I, Kenett RS, Cohen Y, Avivi I, Cohen CJ, Gatt ME, Stepensky P. Kfir-Erenfeld S, et al. Among authors: assayag m. Blood Adv. 2024 Aug 13;8(15):4077-4088. doi: 10.1182/bloodadvances.2024012967. Blood Adv. 2024. PMID: 38768428 Free PMC article. Clinical Trial.
PRECICE nail bending in femur lengthening.
Al Ramlawi A, Assayag M, McClure P. Al Ramlawi A, et al. Among authors: assayag m. J Orthop. 2024 May 18;56:127-132. doi: 10.1016/j.jor.2024.05.018. eCollection 2024 Oct. J Orthop. 2024. PMID: 38828473
Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis.
Kfir-Erenfeld S, Asherie N, Grisariu S, Avni B, Zimran E, Assayag M, Sharon TD, Pick M, Lebel E, Shaulov A, Cohen YC, Avivi I, Cohen CJ, Stepensky P, Gatt ME. Kfir-Erenfeld S, et al. Among authors: assayag m. Clin Cancer Res. 2022 Dec 1;28(23):5156-5166. doi: 10.1158/1078-0432.CCR-22-0637. Clin Cancer Res. 2022. PMID: 36107221 Clinical Trial.
Encapsulated Carbenoxolone Reduces Lung Metastases.
Karsch-Bluman A, Avraham S, Assayag M, Schwob O, Benny O. Karsch-Bluman A, et al. Among authors: assayag m. Cancers (Basel). 2019 Sep 17;11(9):1383. doi: 10.3390/cancers11091383. Cancers (Basel). 2019. PMID: 31533288 Free PMC article.
Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial.
Asherie N, Kfir-Erenfeld S, Avni B, Assayag M, Dubnikov T, Zalcman N, Lebel E, Zimran E, Shaulov A, Pick M, Cohen Y, Avivi I, Cohen C, Gatt ME, Grisariu S, Stepensky P. Asherie N, et al. Among authors: assayag m. Haematologica. 2023 Jul 1;108(7):1827-1839. doi: 10.3324/haematol.2022.281628. Haematologica. 2023. PMID: 36200421 Free PMC article. Clinical Trial.
Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?
Vainstein V, Avni B, Grisariu S, Kfir-Erenfeld S, Asherie N, Nachmias B, Auman S, Saban R, Zimran E, Assayag M, Filanovsky K, Horowitz NA, Lebel E, Shaulov A, Gur M, Rosenbluh C, Krichevsky S, Stepensky P, Gatt ME. Vainstein V, et al. Among authors: assayag m. Cancers (Basel). 2023 Jul 3;15(13):3471. doi: 10.3390/cancers15133471. Cancers (Basel). 2023. PMID: 37444582 Free PMC article.
61 results